An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2010 by Taipei Medical University WanFang Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Taipei Medical University WanFang Hospital

ClinicalTrials.gov Identifier:

NCT01195532

First received: September 3, 2010

Last updated: NA

Last verified: September 2010

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	January 2011
Estimated Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)